Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the <i>LRRK2</i> G2019S Variant-Reference-Cited by-同舟云学术

Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant

Published:2022-08-23 Issue:8 Volume:99 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Saunders-Pullman Rachel¹,Ortega Roberto Angel¹,Wang Cuiling¹,Raymond Deborah¹,Elango Sonya¹,Leaver Katherine¹,Urval Nikita¹,Katsnelson Viktoriya¹,Gerber Rachel¹,Swan Matthew¹,Shanker Vicki¹,Alcalay Roy N.¹^ORCID,Mirelman Anat¹,Brumm Michael C.¹^ORCID,Mejia-Santana Helen¹,Coffey Christopher S.¹,Marek Kenneth¹,Ozelius Laurie J.¹,Giladi Nir¹,Marder Karen S.¹,Bressman Susan B.¹

Affiliation:

1. From the Department of Neurology (R.S.-P., R.A.O., D.R., S.E., K.L., N.U., V.K., R.G., M.S., V.S., S.B.B.), Mount Sinai Beth Israel; Albert Einstein College of Medicine (C.W.), Bronx, NY; Department of Neurology (R.N.A., H.M.-S., K.S.M.), Columbia University Irving Medical Center, New York; Neurological Institute (A.M., N.G.), Tel Aviv Sourasky Medical Center, Sackler School of Medicine and Sagol School of Neurosciences, Tel Aviv University, Israel; University of Iowa Carver College of Medicine (M.C...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000200737

Reference51 articles.

1. LRRK2G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews

2. Leucine-Rich Repeat Kinase 2 in Parkinson’s Disease: Updated from Pathogenesis to Potential Therapeutic Target

3. Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson Disease

4. Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

5. Olfactory identification in LRRK 2 G2019S mutation carriers: a relevant marker?

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of LRRK2 and GBA variants on orthostatic hypotension in patients with Parkinson’s disease;Journal of Neurology;2025-05

2. Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review;Frontiers in Neuroscience;2025-01-07

3. Clinical approach to monogenic Parkinson’s disease;Annals of Movement Disorders;2025-01

4. LRRK2 mutation contributes to decreased free water in the nucleus basalis of Meynert in manifest and premanifest Parkinson’s disease;Journal of Neurology;2024-12-12

5. Genetics of Parkinson's Disease: From Causes to Treatment;Cold Spring Harbor Perspectives in Medicine;2024-08-12